A cost-effectiveness framework for profiling the value of hospital care

Medical Decision Making

Volumn 28, Issue 3, 2008, Pages 419-434

  Timbie, Justin W ^a,c   Newhouse, Joseph P ^a   Rosenthal, Meredith B ^b   Normand, Sharon Lise T ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Cost benefit analysis; Myocardial infarction; Outcome assessment; Risk adjustment

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HEART SURGERY; HOSPITAL; HOSPITAL CARE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MEDICAL INFORMATICS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS;

AGED; COST-BENEFIT ANALYSIS; FEMALE; FINANCING, PERSONAL; HOSPITALIZATION; HUMANS; MALE; MASSACHUSETTS; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; RISK ADJUSTMENT; SURVIVAL ANALYSIS;

EID: 44049092016     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X07312476     Document Type: Article

References (37)

1. Herzlinger RE, Parsa-Parsi R. Consumer-driven health care: lessons from Switzerland. JAMA. 2004 ; 292: 1213-20.
2. Lo Sasso AT, Rice T., Gabel JR, Whitmore H. Tales from the new frontier: pioneers' experiences with consumer-driven health care. Health Serv Res. 2004 ; 39: 1071-90.
3. Fuhrmans V. A big insurer bets on hot trend: shopping around for health care. Wall Street Journal. 2005 Oct 24; A1.
4. Robinson JC Hospital tiers in health insurance: balancing consumer choice with financial incentives. Health Aff (Millwood). 2003 ;Suppl Web Exclusives:W3-135-46.
5. Leapfrog Hospital Rewards Program [homepage on the Inter-net]. The Leapfrog Group. [updated 2006 Jan 31; cited 2006 Feb 2]. Available from: https://leapfrog.medstat.com/hrp/index.asp
6. Hospital Quality Incentive Demonstration [homepage on Inter-net]. Premier, Inc. [updated 2006 ; cited 2006 Feb 2]. Available from: http://www.premierinc.com/all/quality/hqi/
7. Medicare Physician Group Practice Demonstration fact sheet. Office of Research, Development, and Information, Centers for Medicare and Medicaid Services, Department of Health & Human Services. [updated 2005 Jan 31; cited 2007 Jan 10]. Available from: http://www.cms.hhs.gov/DemoProjectsEvalRpts/ downloads/PGP_Fact_Sheet.pdf
8. Care Management for High-Cost Beneficiaries demonstration press release. Office of External Affairs, Centers for Medicare and Medicaid Services, Department of Health & Human Services. [updated 2004 Oct 1; cited 2007 Jan 10. Available from: http://www.cms.hhs.gov/DemoProjectsEvalRpts/downloads/ CMHCB_press_release_10_2004.pdf
9. Krumholz HM, Wang Y., Mattera JA, et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation. 2006 ; 113: 1683-92.
10. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ Variations in the longitudinal efficiency of academic medical centers. Health Aff (Millwood). 2004 ;Suppl Web Exclusive: VAR19-32.
11. Draper D., Gittoes M. Statistical analysis of performance indicators in UK higher education. J R Stat Soc Ser A. 2004 ; 167: 449-74.
12. Normand SL, Glickman ME, Gatsonis CA Statistical methods for profiling providers of medical care: issues and applications. J Am Stat Assoc. 1997 ; 92: 803-14.
13. Burgess JF Jr, Christiansen CL, Michalak SE, Morris CN Medical profiling: improving standards and risk adjustments using hierarchical models. J Health Econ. 2000 ; 19: 291-309.
14. Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association scientific statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group. Circulation. 2006 ; 113: 456-62.
15. Grieve R., Nixon R., Thompson SG, Normand C. Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ. 2005 ; 14: 185-96.
16. Thompson SG, Nixon RM, Grieve R. Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study. J Health Econ. 2006 ; 25: 1015-28.
17. Nixon RM, Thompson SG Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. Health Econ. 2005 ; 14: 1217-29.
18. O'Hagan A., Stevens JW, Montmartin J. Bayesian cost-effectiveness analysis from clinical trial data. Stat Med. 2001 ; 20: 733-53.
19. Willan AR, Briggs AH, Hoch JS Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Econ. 2004 ; 13: 461-75.
20. Willan AR, Pinto EM, O'Brien BJ, et al. Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Econ. 2005 ; 14: 327-38.
21. Spiegelhalter DJ, Abrams KR, Myles JP Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester, UK: John Wiley; 2004.
22. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998 ; 18: S68-80.
23. Viscusi W., Aldy J. The Value of a Statistical Life: A Critical Review of Market Estimates throughout the World. Cambridge, UK: NBER Working Paper Series; 2003.
24. Cutler DM Your Money or Your Life: Strong Medicine for America's Health Care System. New York: Oxford University Press ; 2004.
25. Goldstein H., Speigelhalter D. League tables and their limitation: statistical issues in comparisons of institutional performance (with discussion). J R Stat Soc Ser A. 1996 ; 159: 385-443.
26. Hannan EL, Kilburn H., O'Donnell JF, Lukacik G., Shields EP Adult open heart surgery in New York state: an analysis of risk factors and hospital mortality rates. JAMA. 1990 ; 264: 2768-74.
27. O'Connor GT, Plume SK, Olmstead EM, et al. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 1992 ; 85: 2110-8.
28. Krumholz HM, Wang Y., Mattera JA, et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation. 2006 ; 113: 1693-701.
29. Table 1a. National adjusted operating standardized amounts, labor/nonlabor. Federal Register. 2002 ; 67: 50134.
30. O'Hagan A., Stevens JW A framework for cost-effectiveness analysis from clinical trial data. Health Econ. 2001 ; 10: 303-15.
31. Duan N. Smearing estimate: a non-parametric retransformation method. J Am Stat Assoc. 1983 ; 78: 605-10.
32. Lunn DJ, Thomas A., Best N., Spiegelhalter D. WinBUGS-a Bayesian modelling framework: concepts, structure, and extensibility. Statist Comput. 2000 ; 10: 325-37.
33. Brooks SP, Gelman A. Alternative methods for monitoring convergence of iterative simulations. J Comp Graph Stat. 1998 ; 7: 434-55.
34. Lothgren M., Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ. 2000 ; 9: 623-30.
35. Fenwick E., Claxton K., Sculpher M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ. 2001 ; 10: 779-87.
36. Fenwick E., O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ. 2004 ; 13: 405-15.
37. Committee on Redesigning Health Insurance Performance Measures, Payment, and Performance Improvement Programs. Performance Measurement: Accelerating Improvement. Washington, DC: National Academies Press ; 2006.